The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Scaleable manufacture of HIV-1 entry inhibitor griffithsin and validation of its safety and efficacy as a topical microbicide component
Open accessAbstract
To prevent sexually transmitted HIV, the most desirable active ingredients of microbicides are antiretrovirals (ARVs) that directly target viral entry and avert infection at mucosal surfaces. However, most promising ARV entry inhibitors are biologicals, which are costly to manufacture and deliver to resource-poor areas where effective microbicides are urgently needed. Here, we report a manufacturing breakthrough for griffithsin (GRFT), one of the most potent HIV entry inhibitors. This red algal protein was produced in multigram quantities after extraction from Nicotiana benthamiana plants transduced with a tobacco mosaic virus vector expressing GRFT. Plant-produced GRFT (GRFT-P) was shown as active against HIV at picomolar concentrations, directly virucidal via binding to HIV envelope glycoproteins, and capable of blocking cell-to-cell HIV transmission. GRFT-P has broad-spectrum activity against HIV clades A, B, and C, with utility as a microbicide component for HIV prevention in established epidemics in sub-Saharan Africa, South Asia, China, and the industrialized West. Cognizant of the imperative that microbicides not induce epithelial damage or inflammatory responses, we also show that GRFT-P is nonirritating and noninflammatory in human cervical explants and in vivo in the rabbit vaginal irritation model. Moreover, GRFT-P is potently active in preventing infection of cervical explants by HIV-1 and has no mitogenic activity on cultured human lymphocytes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Current protocols in immunology
Nezlin, R. (1992) · Molecular Immunology · doi:10.1016/0161-5890(92)90114-d · Cited by 1,408
Li, M., Gao, F., Mascola, J. R., Stamatatos, L., Polonis, V. R., Koutsoukos, M., Voss, G., Goepfert, P., Gilbert, P., Greene, K. M., et al. (2005) · Journal of Virology · doi:10.1128/jvi.79.16.10108-10125.2005 · Cited by 1,070
Self-citationEvaluating Neutralizing Antibodies Against HIV, SIV, and SHIV in Luciferase Reporter Gene Assays
Montefiori, D. C. (2004) · Current Protocols in Immunology · doi:10.1002/0471142735.im1211s64 · Cited by 580
Self-citationSetting the stage: host invasion by HIV
Hladik, F., & McElrath, M. J. (2008) · Nature Reviews Immunology · doi:10.1038/nri2302 · Cited by 564
Initial Events in Establishing Vaginal Entry and Infection by Human Immunodeficiency Virus Type-1
Hladik, F., Sakchalathorn, P., Ballweber, L., Lentz, G., Fialkow, M., Eschenbach, D., & McElrath, M. J. (2007) · Immunity · doi:10.1016/j.immuni.2007.01.007 · Cited by 498
Veazey, R. S., Shattock, R. J., Pope, M., Kirijan, J. C., Jones, J., Hu, Q., Ketas, T., Marx, P. A., Klasse, P. J., Burton, D. R., et al. (2003) · Nature Medicine · doi:10.1038/nm833 · Cited by 460
Self-citationMori, T., O'Keefe, B. R., Sowder, R. C., Bringans, S., Gardella, R., Berg, S., Cochran, P., Turpin, J. A., Buckheit, R. W., McMahon, J. B., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m411122200 · Cited by 445
Self-citationLi, M., Salazar-Gonzalez, J. F., Derdeyn, C. A., Morris, L., Williamson, C., Robinson, J. E., Decker, J. M., Li, Y., Salazar, M. G., Polonis, V. R., et al. (2006) · Journal of Virology · doi:10.1128/jvi.01730-06 · Cited by 359
Self-citationPrevention of Vaginal SHIV Transmission in Rhesus Macaques Through Inhibition of CCR5
Lederman, M. M., Veazey, R. S., Offord, R., Mosier, D. E., Dufour, J., Mefford, M., Piatak, M., Lifson, J. D., Salkowitz, J. R., Rodriguez, B., et al. (2004) · Science · doi:10.1126/science.1099288 · Cited by 352
Veazey, R. S., Klasse, P. J., Schader, S. M., Hu, Q., Ketas, T. J., Lu, M., Marx, P. A., Dufour, J., Colonno, R. J., Shattock, R. J., et al. (2005) · Nature · doi:10.1038/nature04055 · Cited by 298
Self-citationGreenhead, P., Hayes, P., Watts, P. S., Laing, K. G., Griffin, G. E., & Shattock, R. J. (2000) · Journal of Virology · doi:10.1128/jvi.74.12.5577-5586.2000 · Cited by 295
Self-citationDissection of the carbohydrate specificity of the broadly neutralizing anti-HIV-1 antibody 2G12
Calarese, D. A., Lee, H.-K., Huang, C.-Y., Best, M. D., Astronomo, R. D., Stanfield, R. L., Katinger, H., Burton, D. R., Wong, C.-H., & Wilson, I. A. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0505763102 · Cited by 294
Blockade of Attachment and Fusion Receptors Inhibits HIV-1 Infection of Human Cervical Tissue
Hu, Q., Frank, I., Williams, V., Santos, J. J., Watts, P., Griffin, G. E., Moore, J. P., Pope, M., & Shattock, R. J. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20022212 · Cited by 224
Self-citationCyanovirin-N Inhibits AIDS Virus Infections in Vaginal Transmission Models
Tsai, C.-C., Emau, P., Jiang, Y., Agy, M. B., Shattock, R. J., Schmidt, A., Morton, W. R., Gustafson, K. R., & Boyd, M. R. (2004) · AIDS Research and Human Retroviruses · doi:10.1089/088922204322749459 · Cited by 212
Self-citationMcCormick, A. A., Reddy, S., Reinl, S. J., Cameron, T. I., Czerwinkski, D. K., Vojdani, F., Hanley, K. M., Garger, S. J., White, E. L., Novak, J., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0803636105 · Cited by 185
Self-citationAntiretroviral Drug–Based Microbicides to Prevent HIV-1 Sexual Transmission
Klasse, P. J., Shattock, R., & Moore, J. P. (2008) · Annual Review of Medicine · doi:10.1146/annurev.med.59.061206.112737 · Cited by 178
Self-citationCyanovirin-N Gel as a Topical Microbicide Prevents Rectal Transmission of SHIV89.6P in Macaques
Tsai, C.-C., Emau, P., Jiang, Y., Tian, B., Morton, W. R., Gustafson, K. R., & Boyd, M. R. (2003) · AIDS Research and Human Retroviruses · doi:10.1089/088922203322230897 · Cited by 172
Ziółkowska, N. E., O'Keefe, B. R., Mori, T., Zhu, C., Giomarelli, B., Vojdani, F., Palmer, K. E., McMahon, J. B., & Wlodawer, A. (2006) · Structure · doi:10.1016/j.str.2006.05.017 · Cited by 172
Self-citationCOMPARISON OF VAGINAL TOLERANCE TESTS OF SPERMICIDAL PREPARATIONS IN RABBITS AND MONKEYS
Eckstein, P. P., JACKSON, M. C. N., MILLMAN, N., et al. (1969) · Reproduction · doi:10.1530/jrf.0.0200085 · Cited by 159
Griffithsin, a potent HIV entry inhibitor, is an excellent candidate for anti‐HIV microbicide
Emau, P., Tian, B., O’Keefe, B., Mori, T., McMahon, J. B., Palmer, K. E., Jiang, Y., Bekele, G., & Tsai, C. (2007) · Journal of Medical Primatology · doi:10.1111/j.1600-0684.2007.00242.x · Cited by 135
Self-citationFletcher, P. S., Kiselyeva, Y., Wallace, G., Romano, J., Griffin, G. E., Margolis, L. B., & Shattock, R. J. (2005) · Journal of Virology · doi:10.1128/jvi.79.17.11179-11186.2005 · Cited by 92
Self-citationBuffa, V., Stieh, D. J., Mamhood, N., Hu, Q., Fletcher, P. S., & Shattock, R. J. (2008) · Journal of General Virology · doi:10.1099/vir.0.004358-0 · Cited by 84
Self-citationTransgenic plant production of Cyanovirin‐N, an HIV microbicide
Sexton, A. L., Drake, P. M. W., Mahmood, N., Harman, S., Shattock, R. J., & K‐C., J. (2005) · The FASEB Journal · doi:10.1096/fj.05-4742fje · Cited by 79
Self-citationBlish, C. A., Nedellec, R., Mandaliya, K. N., et al. (2007) · AIDS · doi:10.1097/qad.0b013e32805e8727 · Cited by 74
Safety concerns for the potential use of cyanovirin-N as a microbicidal anti-HIV agent
Huskens, D., Vermeire, K., Vandemeulebroucke, E., Balzarini, J. M., & Schols, D. (2008) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2008.05.023 · Cited by 73
Ziolkowska, N. E., Shenoy, S. R., O’Keefe, B. R., McMahon, J. B., Palmer, K. E., Dwek, R. A., Wormald, M. R., & Wlodawer, A. (2007) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.21336 · Cited by 67
Self-citationBeer, B., Doncel, G. F., Krebs, F. C., Shattock, R. J., Fletcher, P. S., Buckheit, R. W., Watson, K. M., Dezzutti, C. S., Cummins, J. E., Bromley, E., et al. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.2.713-723.2006 · Cited by 64
Self-citationRecombinant production of anti-HIV protein, griffithsin, by auto-induction in a fermentor culture
Giomarelli, B., Schumacher, K. M., Taylor, T. E., Sowder, R. C., Hartley, J. L., McMahon, J. B., & Mori, T. (2005) · Protein Expression and Purification · doi:10.1016/j.pep.2005.10.014 · Cited by 63
Self-citation
Cited by
Plant-made vaccine antigens and biopharmaceuticals
Daniell, H., Singh, N. D., Mason, H., & Streatfield, S. J. (2009) · Trends in Plant Science · doi:10.1016/j.tplants.2009.09.009 · Cited by 405
O'Keefe, B. R., Giomarelli, B., Barnard, D. L., Shenoy, S. R., Chan, P. K. S., McMahon, J. B., Palmer, K. E., Barnett, B. W., Meyerholz, D. K., Wohlford-Lenane, C. L., et al. (2010) · Journal of Virology · doi:10.1128/jvi.02322-09 · Cited by 303
Self-citationAdvances in plant molecular farming
Obembe, O. O., Popoola, J. O., Leelavathi, S., & Reddy, S. V. (2011) · Biotechnology Advances · doi:10.1016/j.biotechadv.2010.11.004 · Cited by 276
Lee, C. (2019) · Marine Drugs · doi:10.3390/md17100567 · Cited by 138
Lotfi, H., Sheervalilou, R., & Zarghami, N. (2017) · BioImpacts · doi:10.15171/bi.2018.16 · Cited by 30
Metadata
- Authors
- O'Keefe, B. R., Vojdani, F., Buffa, V., Shattock, R. J., Montefiori, D. C., Bakke, J., Mirsalis, J., d'Andrea, A.-L., Hume, S. D., Bratcher, B., Saucedo, C. J., McMahon, J. B., Pogue, G. P., & Palmer, K. E.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2009-04-14
- Volume
- 106
- Issue
- 15
- Pages
- 6099-6104
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2079028174
- Cited by
- 262
- References
- 28
- FWCI
- 18.85
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.